Kishiwada City Hospital

Kishiwada, Osaka 596-8501

0 studies enrolling now · 3 studies all time

What they study most

Metastatic Non-Small Cell Lung Cancer, Relapsed Small Cell Lung Cancer, Severe Asthma

Studies at this site

• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT) — Completed
• A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY) — Running, not enrolling